IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Japan |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Korea, Republic of |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Bolivia, Plurinational State of |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Norway |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
South Africa |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Holy See |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
World Health Organization (WHO) |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
United Nations Conference on Trade and Development (UNCTAD) |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
United Nations Conference on Trade and Development (UNCTAD) |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
World Trade Organization |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
United States of America |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
South Africa |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
India |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Bangladesh on behalf of Least-developed countries |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Brazil |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
South Africa |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
China |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Indonesia |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Nigeria on behalf of African Group |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Egypt |
01/03/2017-02/03/2017 |
07/06/2017 |
|